+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alnylam Pharmaceuticals Inc - logo
Implantable Infusion Pumps Market Analysis & Trends- Application (Cancer Treatment, Cancer Pain, Noncancer Pain, Spasticity, Analgesia, Mixed Sarcoma and Skin Cancers, Gastric Cancer and Diabetes Mellitus) - Forecast to 2025 - Product Thumbnail Image

Implantable Infusion Pumps Market Analysis & Trends- Application (Cancer Treatment, Cancer Pain, Noncancer Pain, Spasticity, Analgesia, Mixed Sarcoma and Skin Cancers, Gastric Cancer and Diabetes Mellitus) - Forecast to 2025

  • Report
  • October 2016
  • 159 Pages
From
Hepatitis Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Hepatitis Drug Development Pipeline Review, 2018

  • Report
  • June 2018
  • 133 Pages
From
Global Hepatocellular Carcinoma Drug Sales (Nexavar & Miripla), Pipeline Analysis and Global Market Forecast 2022 - Product Thumbnail Image

Global Hepatocellular Carcinoma Drug Sales (Nexavar & Miripla), Pipeline Analysis and Global Market Forecast 2022

  • Report
  • April 2017
  • 70 Pages
From
Sorafenib Market Insights 2019, Analysis and Forecast Global and Chinese Market to 2024, by Manufacturers, Product Type, Application, Regions and Technology - Product Thumbnail Image

Sorafenib Market Insights 2019, Analysis and Forecast Global and Chinese Market to 2024, by Manufacturers, Product Type, Application, Regions and Technology

  • Report
  • June 2019
  • 138 Pages
From
Hyperoxaluria Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Hyperoxaluria Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • May 2018
  • 72 Pages
From
Thalassemia Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Thalassemia Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • May 2018
  • 98 Pages
From
Hemochromatosis Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Hemochromatosis Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • March 2018
  • 85 Pages
From
Hepcidin Antagonist -Pipeline Insight, 2019 - Product Thumbnail Image

Hepcidin Antagonist -Pipeline Insight, 2019

  • Drug Pipelines
  • January 2019
  • 60 Pages
From
Hemoglobinopathies Market Size, Share & Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Therapy, By Diagnosis, By Region, And Segment Forecasts, 2019 - 2026 - Product Thumbnail Image

Hemoglobinopathies Market Size, Share & Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Therapy, By Diagnosis, By Region, And Segment Forecasts, 2019 - 2026

  • Report
  • May 2019
  • 100 Pages
From
Hepatitis D - Pipeline Insight, 2019 - Product Thumbnail Image

Hepatitis D - Pipeline Insight, 2019

  • Drug Pipelines
  • January 2019
  • 50 Pages
From
Global Hematology Partnering 2014-2019: Deal trends, players and financials - Product Thumbnail Image

Global Hematology Partnering 2014-2019: Deal trends, players and financials

  • Report
  • December 2019
  • 170 Pages
From
2019 Hemophilia B Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Hemophilia B Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 103 Pages
From
2019 Hemoglobinuria Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Hemoglobinuria Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 82 Pages
From
2019 Paroxysmal Nocturnal Hemoglobinuria Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Paroxysmal Nocturnal Hemoglobinuria Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 69 Pages
From
2019 Atypical Hemolytic Uremic Syndrome (Nondiarrhea Associated Hemolytic Uremic Syndrome) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Atypical Hemolytic Uremic Syndrome (Nondiarrhea Associated Hemolytic Uremic Syndrome) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 46 Pages
From
NASH Drugs Market, 2015 - 2025 - Product Thumbnail Image

NASH Drugs Market, 2015 - 2025

  • Report
  • September 2015
  • 188 Pages
From
Transthyretin Amyloidosis (ATTR)- Market Insights, Epidemiology and Market Forecast - Product Thumbnail Image

Transthyretin Amyloidosis (ATTR)- Market Insights, Epidemiology and Market Forecast

  • Drug Pipelines
  • November 2018
  • 120 Pages
From
Global Liver Cancer Treatment Market Research and Forecast, 2018-2023 - Product Thumbnail Image

Global Liver Cancer Treatment Market Research and Forecast, 2018-2023

  • Report
  • January 2019
From
Global Liver Cancer Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025 - Product Thumbnail Image

Global Liver Cancer Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

  • Report
  • November 2019
  • 105 Pages
From
Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • November 2018
  • 66 Pages
From
Loading Indicator
adroll